MHRA Safety Update: May 2024 Recalls and Letters
The MHRA has published a summary of letters and safety notifications issued to healthcare professionals during May 2024. This update covers recent medicines and medical device alerts that may affect your clinical practice and patient care.
What You Need to Know
The MHRA regularly communicates important safety information to healthcare professionals through targeted letters and recall notices. These communications highlight emerging safety concerns, product defects, or regulatory actions that require awareness across primary and secondary care settings.
Key Actions
- Review the full MHRA alert to identify any medicines or devices relevant to your service
- Check whether your organisation stocks or prescribes any affected products
- Ensure clinical and pharmacy teams are briefed on any local implications
- Report any adverse events or product issues to the MHRA via the Yellow Card scheme
Access the Full Alert
For the complete list of May 2024 recalls, letters, and safety updates, visit the MHRA drug safety update page.
Staying informed about medicines safety is essential for all clinical responders and event medical teams. If you have questions about any recalled product or safety concern, contact your local medicines information service or pharmacy team.